Sino Biopharmaceutical reported CNY31.96B in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Avita Medical AUD 4.5M 19.42M Dec/2024
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Jiangsu Hengrui CNY 58.69B 11.7B Jun/2025
Moderna USD 9.4B 667M Jun/2025
Organon & Co USD 733M 191M Jun/2025
Revvity USD 7.64B 29.74M Mar/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025